文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

残留肿瘤微灶和大量调节性T淋巴细胞浸润是膀胱癌复发的原因。

Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.

作者信息

Parodi Alessia, Traverso Paolo, Kalli Francesca, Conteduca Giuseppina, Tardito Samuele, Curto Monica, Grillo Federica, Mastracci Luca, Bernardi Cinzia, Nasi Giorgia, Minaglia Francesco, Simonato Alchiede, Carmignani Giorgio, Ferrera Francesca, Fenoglio Daniela, Filaci Gilberto

机构信息

Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.

Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.

出版信息

Oncotarget. 2016 Feb 9;7(6):6424-35. doi: 10.18632/oncotarget.7024.


DOI:10.18632/oncotarget.7024
PMID:26824503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4872724/
Abstract

Bladder cancer has an unexplained, high recurrence rate. Causes of recurrence might include the presence of sporadic tumor micro-foci in the residual urothelial tissue after surgery associated with an inverted ratio between intratumoral effector and regulatory T cell subsets. Hence, surgical specimens of both tumors and autologous, macroscopically/histologically free-of-tumor tissues were collected from 28 and 20 patients affected by bladder or renal cancer, respectively. The frequencies of effector (IFNγ+ and IL17+ T cells) and regulatory (CD4+CD25hiCD127lo and CD8+CD28-CD127loCD39+ Treg) T cell subpopulations among tumor infiltrating lymphocytes were analyzed by immunofluorescence, while the gene expression of MAGE-A1 and MAGE-A2 tumor-associated antigens was studied by RT-PCR. The results show that both the T cell infiltrate and the frequency of MAGE-A1/A2 gene expression were comparable in tumors and in autologous free-of-tumor tissues in bladder cancer, while the autologous free-of-tumor renal tissues showed reduced T cell infiltrate and frequency of MAGE gene expression as compared to the autologous tumors. Importantly, the intra-tumor T effector/Treg cell ratio was consistently <1 in bladder cancer patients (n. 7) who relapsed within two years, while it was always >1 in patients (n. 6) without recurrence (regardless of tumor stage) (P = 0.0006, Odds ratio = 195). These unprecedented findings clarify the pathogenic mechanism of bladder cancer recurrence and suggest that microscopically undetectable micro-foci of tumor may predispose to recurrence when associated with an inverted intratumoral T effector/Treg cell ratio.

摘要

膀胱癌具有无法解释的高复发率。复发原因可能包括手术后残余尿路上皮组织中存在散发性肿瘤微灶,这与肿瘤内效应性和调节性T细胞亚群之间的倒置比例有关。因此,分别从28例膀胱癌患者和20例肾癌患者中收集肿瘤手术标本以及自体的、宏观/组织学上无肿瘤的组织。通过免疫荧光分析肿瘤浸润淋巴细胞中效应性(IFNγ+和IL17+ T细胞)和调节性(CD4+CD25hiCD127lo和CD8+CD28-CD127loCD39+ Treg)T细胞亚群的频率,同时通过RT-PCR研究MAGE-A1和MAGE-A2肿瘤相关抗原的基因表达。结果表明,在膀胱癌中,肿瘤组织和自体无肿瘤组织中的T细胞浸润以及MAGE-A1/A2基因表达频率相当,而与自体肿瘤相比,自体无肿瘤的肾组织中T细胞浸润和MAGE基因表达频率降低。重要的是,在两年内复发的膀胱癌患者(n = 7)中,肿瘤内T效应细胞/Treg细胞比值始终<1,而在无复发的患者(n = 6)中(无论肿瘤分期如何)该比值始终>1(P = 0.0006,优势比 = 195)。这些前所未有的发现阐明了膀胱癌复发的致病机制,并表明当与肿瘤内T效应细胞/Treg细胞比值倒置相关时,显微镜下不可检测的肿瘤微灶可能易导致复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/5e45363a71d4/oncotarget-07-6424-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/0d3e0f78dc1b/oncotarget-07-6424-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/29fbb2d81d46/oncotarget-07-6424-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/777de985833f/oncotarget-07-6424-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/9d110540acae/oncotarget-07-6424-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/1d477da27468/oncotarget-07-6424-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/5e45363a71d4/oncotarget-07-6424-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/0d3e0f78dc1b/oncotarget-07-6424-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/29fbb2d81d46/oncotarget-07-6424-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/777de985833f/oncotarget-07-6424-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/9d110540acae/oncotarget-07-6424-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/1d477da27468/oncotarget-07-6424-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dea7/4872724/5e45363a71d4/oncotarget-07-6424-g006.jpg

相似文献

[1]
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.

Oncotarget. 2016-2-9

[2]
Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.

Am J Clin Oncol. 2013-6

[3]
Prediction of recurrence and survival in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells.

Cancer Prev Res (Phila). 2013-4-18

[4]
The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.

World J Urol. 2016-2

[5]
CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.

J Urol. 2015-3-6

[6]
Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.

Int J Cancer. 2007-1-15

[7]
A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).

Ann Surg Oncol. 2016-3

[8]
The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.

Oncotarget. 2016-2-16

[9]
A potential role for 6-sulfo sialyl Lewis X in metastasis of bladder urothelial carcinoma.

Urol Oncol. 2015-11

[10]
CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.

Ann Surg Oncol. 2014-6

引用本文的文献

[1]
Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma.

Diagnostics (Basel). 2022-11-29

[2]
Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.

Front Oncol. 2022-9-23

[3]
BCG invokes superior STING-mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer.

J Pathol. 2022-2

[4]
The Tumor Microenvironment of Bladder Cancer.

Adv Exp Med Biol. 2020

[5]
Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer.

Heliyon. 2020-12-1

[6]
Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer.

PLoS One. 2020-6-2

[7]
Expression of miR-490-5p, miR-148a-3p and miR-608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells.

Oncol Lett. 2019-5

[8]
Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy.

J Urol. 2019-6

[9]
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer.

J Cancer Res Clin Oncol. 2018-12-11

[10]
Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens.

PLoS One. 2018-9-27

本文引用的文献

[1]
Factors affecting immunoreactivity in long-term storage of formalin-fixed paraffin-embedded tissue sections.

Histochem Cell Biol. 2015-7

[2]
Bladder cancers arise from distinct urothelial sub-populations.

Nat Cell Biol. 2014-9-14

[3]
Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

Cancer Res. 2013-12-23

[4]
Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

J Pathol. 2014-1

[5]
IL-17A promotes immune cell recruitment in human esophageal cancers and the infiltrating dendritic cells represent a positive prognostic marker for patient survival.

J Immunother. 2013-10

[6]
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.

Cancer Res. 2013-4-16

[7]
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes.

Cancer Immunol Immunother. 2013-1-29

[8]
Induced and natural regulatory T cells in human cancer.

Expert Opin Biol Ther. 2012-7-31

[9]
Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.

Autoimmun Rev. 2012-5-23

[10]
Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.

Breast Cancer Res. 2011-4-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索